Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
This is the 2010 version of HCPCS G9132 - please refer to the 2016 HCPCS code set for the latest version.
Added on Monday, January 01, 2007
Status changed on Monday, January 01, 2007 to: No maintenance for this code
